BofA/Merrill Lynch Downgrades Dr. Reddy's Laboratories (RDY) to Underperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Morgan Stanley Downgrades Dr. Reddy's Laboratories (RDY) to Equalweight
May 14, 2014 7:32 AM EDTMorgan Stanley downgraded Dr. Reddy's Laboratories (NYSE: RDY) from Overweight to Equalweight.
For an analyst ratings summary and ratings history on Dr. Reddy's Laboratories click here. For more ratings news on Dr. Reddy's Laboratories click here.
Shares of Dr. Reddy's Laboratories closed at $43.82 yesterday.
... MoreDr. Reddys Labs (RDY) Reports Q4 EPS of $0.47
May 13, 2014 7:03 AM EDTDr. Reddys Labs (NYSE: RDY) reported Q4 EPS of $0.47, versus $0.56 reported last year. Revenue for the quarter came in at $580 million, versus $557 million reported last year.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.
... More